ES2130426T3 - Vacuna que contiene una serina-proteasa. - Google Patents

Vacuna que contiene una serina-proteasa.

Info

Publication number
ES2130426T3
ES2130426T3 ES94917738T ES94917738T ES2130426T3 ES 2130426 T3 ES2130426 T3 ES 2130426T3 ES 94917738 T ES94917738 T ES 94917738T ES 94917738 T ES94917738 T ES 94917738T ES 2130426 T3 ES2130426 T3 ES 2130426T3
Authority
ES
Spain
Prior art keywords
protease
serine
vaccine containing
fight
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94917738T
Other languages
English (en)
Inventor
John Pius Dalton
Stuart John Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2130426T3 publication Critical patent/ES2130426T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE PROTEASAS DE SERINA CON UNA ACTIVIDAD PEPTIDASA DIPEPTIDIL EN LA FORMULACION DE VACUNAS PARA COMBATIR LOS PARASITOS DE HELMINTO, PREFERIBLEMENTE LA PROTEASA SE DERIVA DE UNA LOMBRIZ TAL COMO LA FASCIOLA HEPATICA.
ES94917738T 1993-06-15 1994-06-14 Vacuna que contiene una serina-proteasa. Expired - Lifetime ES2130426T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939312324A GB9312324D0 (en) 1993-06-15 1993-06-15 Vaccine

Publications (1)

Publication Number Publication Date
ES2130426T3 true ES2130426T3 (es) 1999-07-01

Family

ID=10737190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94917738T Expired - Lifetime ES2130426T3 (es) 1993-06-15 1994-06-14 Vacuna que contiene una serina-proteasa.

Country Status (14)

Country Link
US (1) US5885814A (es)
EP (1) EP0703789B1 (es)
JP (1) JPH08511262A (es)
AT (1) ATE176402T1 (es)
AU (1) AU694121B2 (es)
DE (1) DE69416405T2 (es)
DK (1) DK0703789T3 (es)
ES (1) ES2130426T3 (es)
GB (1) GB9312324D0 (es)
GR (1) GR3030116T3 (es)
HU (1) HUT71209A (es)
NZ (1) NZ267139A (es)
WO (1) WO1994028925A1 (es)
ZA (1) ZA944241B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) * 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
AUPO767497A0 (en) * 1997-07-04 1997-07-24 Australian Wool Research & Promotion Organisation Parasite vaccine
US20030065382A1 (en) * 2001-10-02 2003-04-03 Fischell Robert E. Means and method for the treatment of coronary artery obstructions
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
EP1745292A2 (en) 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
EP2485725A2 (en) 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
DE112017002105T5 (de) * 2016-04-21 2019-04-25 Sphingotec Therapeutics Gmbh Verfahren zur Bestimmung von DPP3 und therapeutische Verfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001277A1 (en) * 1986-08-18 1988-02-25 The Australian National University Helminth parasite vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
NZ230773A (en) * 1988-09-26 1993-04-28 Biotech Australia Pty Ltd Nematode antigenic peptides and vaccines
EP0666919B1 (en) * 1992-10-21 2003-05-14 John Pius Dalton Vaccine containing a thiol protease

Also Published As

Publication number Publication date
DK0703789T3 (da) 1999-09-20
WO1994028925A1 (en) 1994-12-22
NZ267139A (en) 1998-01-26
HUT71209A (en) 1995-11-28
HU9403591D0 (en) 1995-03-28
AU694121B2 (en) 1998-07-16
GR3030116T3 (en) 1999-07-30
JPH08511262A (ja) 1996-11-26
EP0703789B1 (en) 1999-02-03
ZA944241B (en) 1995-05-26
DE69416405D1 (de) 1999-03-18
EP0703789A1 (en) 1996-04-03
GB9312324D0 (en) 1993-07-28
ATE176402T1 (de) 1999-02-15
DE69416405T2 (de) 1999-09-09
US5885814A (en) 1999-03-23
AU6933394A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
DK0656888T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer
ES2155069T3 (es) Inhibidores de proteasas retrovirales.
ES2104946T3 (es) Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2096554T3 (es) Detergentes liquidos.
ES2192708T3 (es) Combinaciones de productos activos fungicidas.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ES2105999T1 (es) Procedimiento para la preparacion industrial de fosfatidilserina.
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
ES2096018T3 (es) Goma gelana para geles no quebradizos.
GT200000111A (es) Procedimiento para la obtencion de preparados farmaceuticos solidos de disgregacion rapida.
ES2130426T3 (es) Vacuna que contiene una serina-proteasa.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ATE240397T1 (de) Thiolprotease enthaltender impfstoff
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2169420T3 (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para tratar enfermedades proliferativas.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
ES2060076T3 (es) Nuevos derivados de tetralina.
ES2133328T3 (es) Enzimas de detergente de verticillium.
ES2129563T3 (es) Empleo de una combinacion de un inhibidor de la enzima convertidora de angiotensina y un antagonista del calcio para el tratamiento de una proteinuria.
ES2073174T3 (es) Nuevas proteasas.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
HN1999000126A (es) Formulaciones plaguicidas que contienen tensoactivos de acido sulfonico aromatico neutralizado como amina alcoxilada.
ES2117362T3 (es) Composicion cosmetica o farmaceutica que contiene un carbamato de alquilo como agente hidratante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 703789

Country of ref document: ES